PRIME Journal is part of the Informa Markets Division of Informa PLC

Informa PLC
About us
Investor relations
Talent

PRIME Journal is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Injectables
Dermatology
Anti-ageing
Body Contouring
Invasive treatments

Home
Aesthetic features
News
Industry Insider
Practice Management
Case Study
Events
Digital Magazine
Register

Select Page

Treatment options for mild to moderate rhinophyma

Nov 4, 2013 | 2 |

ABSTRACT Rhinophyma is an end-stage disease process of rosacea. These patients will usually present to dermatologic and cosmetic surgery offices

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

New User RegistrationFirst Name*

Last Name*

Job Title*

Email*

Choose a Username*

Do you wish to receive FREE digital copies of PRIME and Subscribe to PRIME Newsletter?*

Yes
No

Do you wish to receive printed copies of PRIME? (€180 per annum)*

Yes
No

Would you like to join the Aesthetic Multispecialty Society? Find out more here: https://multispecialtysociety.com/*

Yes contact me for a basic membership
Yes contact me for a Premium membership
No thank you

Would you like to receive occasional offers from other select Informa Group and third parties?*

Yes
No

Address 1*

Address 2

City*

State*

Zip*

Country*

Password*

Confirm Password*

* Please indicate that you agree to the Terms of Service

*Required field

Pages: 1 2

Share:

Rate:

PreviousBiology, fundamentals and safety of lipofilling: current standings of ‘the liquid gold’

NextVelaShape® III: mastering the art of body treatments

Search

Search for:

Recent Posts

Cellulex® The First Ever Subcutaneous Injectable Indicated For Buttock Cellulite Correction
The Aesthetic Society Releases Annual Statistics Revealing Americans Spent Over $9 Billion on Aesthetic Plastic Surgery in 2020
New skinbetter science® Solo Hydrating Defense™ for Men
Revision Skincare® appoint AestheticSource as official distribution brand representative for the UK & Ireland
Delay Surgery by 7 Weeks After COVID Diagnosis: Study

Login Status

Username or Email

Password

Forgot? Register

Upcoming Events

AMWC ASIA

Start date: May 1, 2021 - End date: May 2, 2021

Location: Taipei, Taiwan

AMS VIRTUAL CONFERENCE

Start date: June 3, 2021 - End date: June 4, 2021

Miami Cosmetic Surgery & Aesthetic Dermatology 2021

Start date: August 26, 2021 - End date: August 28, 2021

Location: Miami Beach, FL, USA

AMWC 2021

Start date: September 16, 2021 - End date: September 18, 2021

Location: Monte Carlo, Monaco

Recent Tweets

The Aesthetic Society Releases Annual Statistics Revealing Americans Spent Over $9 Billion on Aesthetic Plastic Sur�twitter.com/i/web/status/1…0U
1 week ago • Reply • Retweet • Favorite
GetHarley, the tech platform that enables and empowers practitioners to sell skincare, is launching a new campaign�twitter.com/i/web/status/1…UJ
4 weeks ago • Reply • Retweet • Favorite
Neauvia is thrilled to announce Neauvia Prime Time, a never seen before Talk Show in the medical aesthetic industry�twitter.com/i/web/status/1…Yg
1 month ago • Reply • Retweet • Favorite
The first issue of PRIME Journal 2021 is out! Read your free digital mag here: lnkd.in/gymA6ev�twitter.com/i/web/status/1…m1
2 months ago • Reply • Retweet • Favorite
In the News: Laser Treatment Improved the Appearance of Acne Scars in Asians bit.ly/3c64wK9�twitter.com/i/web/status/1…Vq
3 months ago • Reply • Retweet • Favorite

Follow @PrimeJournal

Categories

Injectables
Dermatology
Anti-ageing
Body Contouring
Invasive treatments
Case Study
Practice Management
Sponsored
Industry Insider
Company Profile
PRIME People
Meeting reviews
Commentary

Copyright © 2021. All rights reserved. Informa Markets, a trading division of Informa PLC.

Accessibility
Privacy Policy
Cookie Policy
Terms of use
Visitor Terms and Conditions Link